Humacyte Inc.

1.45
-0.04 (-2.68%)
At close: Apr 02, 2025, 3:59 PM
1.45
0.00%
After-hours: Apr 02, 2025, 07:57 PM EDT

Humacyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net Income -148.7M -110.78M -11.96M -26.48M -66.52M -85.42M
Depreciation & Amortization 5.1M 7.72M 8.21M 8.24M 8.35M 6.75M
Stock-Based Compensation 6.14M 6.83M 6.18M 10.15M 4.69M 4.46M
Other Working Capital n/a 1.73M 1.39M -116K 289K 638K
Other Non-Cash Items 39.34M 16.35M -74.41M -54.74M 103K 1.98M
Deferred Income Tax n/a n/a -173K -17.8M 177K -4.27M
Change in Working Capital n/a 6.57M 1.03M -557K -2.37M 453K
Operating Cash Flow -98.12M -73.31M -71.13M -81.19M -55.57M -71.79M
Capital Expenditures -1.57M -2.28M -1.05M -220K -318K -8.13M
Acquisitions n/a n/a -5.89M n/a 50K n/a
Purchase of Investments n/a n/a -10.11M -8M n/a n/a
Sales Maturities Of Investments n/a 2.11M 16M n/a n/a n/a
Other Investing Acitivies n/a n/a 5.89M -8M 50K n/a
Investing Cash Flow -1.57M -173K 4.84M -8.22M -268K -8.13M
Debt Repayment n/a -34.07M -1.98M 27.93M 1.75M -1.29M
Common Stock Repurchased 708K n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 114.18M 38.57M 535K 239.05M 301K 1.22M
Financial Cash Flow 114.18M 4.51M -1.45M 266.98M 2.05M -74K
Net Cash Flow 14.49M -68.97M -67.73M 177.57M -53.78M -79.99M
Free Cash Flow -99.69M -75.58M -72.18M -81.41M -55.89M -79.91M